The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is neratinib following trastuzumab in early-stage HER2-positive breast cancer cost-effective?
 
Naomi RM Schwartz
No Relationships to Disclose
 
Meghan Rose Flanagan
No Relationships to Disclose
 
Joseph B Babigumira
No Relationships to Disclose
 
Lotte Maria Gertruda Steuten
Consulting or Advisory Role - Agendia; Roche Pharma AG (I)
Research Funding - EMD Serono (Inst); Nohla Therapeutics (Inst); Personalized Medicine Coalition (Inst); Thermo Fisher Scientific
 
Joshua A. Roth
No Relationships to Disclose